伝統医薬データベース　

サイト内検索結果「」

全16,670件中、3,541件～3,560件を表示しています。
[1] ・・・ [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] ・・・ [834]

7081. [生薬成分の代謝] 代謝マップ『Hesperetin 7-glucoside』

Hesperetin 7-glucoside ラット Hesperetin 7-glucoside 19393110 1) Véronique Habauzit, Inge-Lise Nielsen, Angel Gil-Izquierdo, Anna Trzeciakiewicz, Christine Morand, Winnie Chee, Denis Barron, Patrice Leb

7082. [生薬成分の代謝] 代謝マップ『Hesperetin』

Hesperetin ラット (2R)-Hesperetin,(2S)-Hesperetin Intravenous administration,Intravenous administration,Intravenous administration,Intravenous administration 18058792 1) Jaime A. Yàñez, Connie M. Remsber

7083. [生薬成分の代謝] 代謝マップ『Homoeriodictyol』

Homoeriodictyol ラット (-)-Homoeriodictyol,(+)-Homoeriodictyol 17719196 1) Karina R. Vega-Villa, Jaime A. Yàñez, Connie M. Remsberg, Yusuke Ohgami, Neal M. Davies, Stereospecific high-performance liquid

7084. [生薬成分の代謝] 代謝物『3-(3-hydroxy-5-methoxyphenyl)propanoic acid』

3-(3-hydroxy-5-methoxyphenyl)propanoic acid 3-(3-hydroxy-5-methoxyphenyl)propanoic acid C10H12O4 196.203 196.0736 197.0814 195.0657 Sinapic acid 代謝物

7085. [生薬成分の代謝] 代謝物『(E)-4-methyl-6-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)hex-4-enoic acid』

(E)-4-methyl-6-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)hex-4-enoic acid (E)-4-methyl-6-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)hex-4-enoic acid C16H20O4 276.332 276.1362 277.144 2

7086. [生薬成分の代謝] 代謝パラメータ『Oral administration』

Oral administration 0.12 ± 0.02 1/h 5.68 ± 0.65 h 0.33 ± 0.02 h 13.66 ± 1.71 μg/ml 69.8 ± 7.10 (μg/ml) x h 62.49 ± 6.67 (μg/ml) x h 0-∞ 0-t Geniposide 代謝パラメータ

7087. [生薬成分の代謝] 代謝パラメータ『Intravenous administration』

Intravenous administration 0.02 mg/kg 56 ± 12 ng/ml 0.049 ± 0.007 min^-1 16 ± 2 min 3.4 ± 0.9 ng/ml 0.004 ± 0.001 min^-1 246 ± 91.3 min 0.41 ± 0.09 l/kg 1.7 ± 0.4 l/kg 10 ± 2 mlkg^-1min^-1 2055

7088. [生薬成分の代謝] 代謝物『(R)-2-(((2S,3S)-4-((E)-3-((R)-1-carboxy-2-(4-hydroxy-3-methoxyphenyl)ethoxy)-3-oxoprop-1-en-1-yl)-7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-2,3-dihydrobenzofuran-3-carbonyl)oxy)-3-(4-hydroxy-3-methoxyphenyl)propanoic acid』

(R)-2-(((2S,3S)-4-((E)-3-((R)-1-carboxy-2-(4-hydroxy-3-methoxyphenyl)ethoxy)-3-oxoprop-1-en-1-yl)-7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-2,3-dihydrobenzofuran-3-carbonyl)oxy)-3-(4-hydroxy-3-methoxyph

7089. [生薬成分の代謝] 代謝パラメータ『Oral administration』

Oral administration 50 mg/kg 30 min 129 ± 17.7 pmol/ml 12654 pmol・min/ml 0-10 h Saikosaponin 代謝パラメータ

7090. [生薬成分の代謝] 代謝物『Anhydroshikonin』

(E)-5,8-dihydroxy-2-(4-methylpenta-1,3-dien-1-yl)naphthalene-1,4-dione Anhydroshikonin C16H14O4 270.285 270.0892 271.097 269.0814 Shikonin 代謝物

7091. [生薬成分の代謝] 代謝マップ『Notoginsenoside R1』

Notoginsenoside R1 ラット Notoginsenoside R1 Intravenous administration,Intravenous administration,Intravenous administration,Intravenous administration,Intravenous administration 17385805 1) Xiaoyu Li,

7092. [生薬成分の代謝] 代謝マップ『Osthol (Osthole)』

Osthol (Osthole) ラット Osthol,Osthenol,7-Methoxy-8-(3-methyl-1,3-butadienyl)-2H-1-benzopyran-2-one Oral administration 18006391, 20055137, 19304430 1) Man Liu, Huiping Liu, Xiumei Lu, Chao Li, Zhili Xio

7093. [生薬成分の代謝] 代謝物『2,3,5-trimethyl-6-(2-(2-methyl-5-oxotetrahydrofuran-2-yl)ethyl)cyclohexa-2,5-diene-1,4-dione』

2,3,5-trimethyl-6-(2-(2-methyl-5-oxotetrahydrofuran-2-yl)ethyl)cyclohexa-2,5-diene-1,4-dione 2,3,5-trimethyl-6-(2-(2-methyl-5-oxotetrahydrofuran-2-yl)ethyl)cyclohexa-2,5-diene-1,4-dione C16H20O4 276.

7094. [生薬成分の代謝] 代謝物『(R)-2-(((E)-3-((2S,3S)-3-(((R)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy)carbonyl)-7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-2,3-dihydrobenzofuran-4-yl)acryloyl)oxy)-3-(4-hydroxy-3-methoxyphenyl)propanoic acid』

(R)-2-(((E)-3-((2S,3S)-3-(((R)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy)carbonyl)-7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-2,3-dihydrobenzofuran-4-yl)acryloyl)oxy)-3-(4-hydroxy-3-methoxyphenyl)propanoic

7095. [生薬成分の代謝] 代謝物『Shikometabolin D』

(6S,13S)-1,4,8,11-tetrahydroxy-6,13-bis(2-methylprop-1-en-1-yl)-6,6a-dihydropentaleno[1,2-b:4,5-b']dinaphthalene-5,7,12,14(5bH,13H)-tetraone Shikometabolin D 154277-73-3 C32H26O8 538.554 538.1628 539.

7096. [生薬成分の代謝] 代謝マップ『Icariside I』

Icariside I ラット Icariside I Intragastric administration,Oral administration 20378425, 18006391, 17706393 1) Haiyu Zhao, Miaoxuan Fan, Li Fan, Jianghao Sun and Dean Guo: Liquid chromatography–tandem ma

7097. [生薬成分の代謝] 代謝マップ『Methylephedrine』

Methylephedrine ヒト Methylephedrine 19492345 1) Yan-Ming Liu, Wei Tian, Yu-Xiu Jia and Hai-Yan Yue, Simultaneous determination of methylephedrine and pseudoephedrine in human urine by CE with electroc

7098. [生薬成分の代謝] 代謝物『4-Hydroxynorephedrine』

4-((1R,2S)-2-amino-1-hydroxypropyl)phenol 4-Hydroxynorephedrine 771-91-5 C9H13NO2 167.208 167.0946 168.1025 166.0868 Ephedrine 代謝物

7099. [生薬成分の代謝] 代謝マップ『Icariside II』

Icariside II ラット Icariside II Intragastric administration,Oral administration 20378425, 18006391, 17706393 1) Haiyu Zhao, Miaoxuan Fan, Li Fan, Jianghao Sun, Dean Guo, Liquid chromatography–tandem mas

7100. [生薬成分の代謝] 代謝マップ『Pseudoephedrine』

Pseudoephedrine ヒト Pseudoephedrine 19492345 1) Yan-Ming Liu, Wei Tian, Yu-Xiu Jia and Hai-Yan Yue, Simultaneous determination of methylephedrine and pseudoephedrine in human urine by CE with electroc

[1] ・・・ [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] ・・・ [834]
全16,670件中、3,541件～3,560件を表示しています。

ページの上へ戻る

TOPICS

生薬

漢方

試験薬物

遺伝子解析情報

化学分析情報

活性試験情報

生薬成分の代謝情報

探索研究